Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal
Version of Record online: 25 JUL 2012
Copyright © 2012 Wiley Periodicals, Inc.
Journal of Surgical Oncology
Volume 107, Issue 4, pages 422–427, 15 March 2013
How to Cite
Wang, Q., Yu, T., Yuan, Y., Zhuang, H., Wang, Z., Liu, X. and Feng, M. (2013), Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal. J. Surg. Oncol., 107: 422–427. doi: 10.1002/jso.23227
- Issue online: 19 FEB 2013
- Version of Record online: 25 JUL 2012
- Manuscript Accepted: 29 JUN 2012
- Manuscript Received: 27 FEB 2012
Additional supporting information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.